Vasquez, Karen

Karen M Vasquez

Professor, Adjunct/Clinical Affiliate
College of Pharmacy

James T. Doluisio Regents Professor in Pharmacy


karen.vasquez@austin.utexas.edu

Phone: 512-495-3040

Office Location
DPI 2.214

Postal Address
The University of Texas at Austin
College of Pharmacy
1 University Station A1900
Austin, TX 78712

Our research efforts are focused in three general areas within an overall theme of genome instability, DNA damage and mechanisms of repair. A unique feature of our approach is an emphasis on the role of DNA structure, including non-canonical structures such as triplex DNA, as recognition sites for repair machinery, sources of genomic instability, and as a basis for technology to target DNA damage to specific genomic sites. 1. DNA structure in genomic instability and human disease. The consequences of genomic instability are causative factors for several human diseases that involve repetitive DNA sequences. Many repetitive sequences are able to adopt non-B secondary structures. Interestingly, many of these repeats occur near breakpoints of chromosomal translocations, implicating them in cancer etiology. Our studies will determine the mutagenic potential and mechanistic role of non-canonical DNA structures in human disease, with an emphasis on translocation-mediated cancers. 2. Molecular mechanisms of DNA damage recognition and repair. Defects in DNA repair systems can lead to severe clinical disorders; for example, it is estimated that ~90% of human cancers result from improperly repaired DNA damage. Our work aims to elucidate the molecular basis of damage recognition in order to develop a better understanding of the mutagenic potential and cancer risks of different types of DNA lesions. 3. Novel strategies to modify gene structure and function in living organisms. An area of intense investigation in my laboratory is the development of triplex technology to improve the existing gene targeting methods by directing damage to specific genomic sites to increase the frequency of recombination and to direct gene inactivation. Our objective is to improve the utility of triplex technology as a tool for genetic manipulation in animals and to develop novel therapeutic strategies for treating cancer.